FDA Inspection 945426 — Ursapharm Arzneimittel GmbH
The FDA completed an inspection of Ursapharm Arzneimittel GmbH on September 25, 2015 in Saarbrucken. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 25, 2015
- Fiscal Year
- 2015
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Saarbrucken (Germany)